Drug-labels.com

Pramipexole (Cobalt Pharmaceuticals): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Pre Market
Strength:
0.25 mg, 0.5 mg, 1.0 mg, 1.5 mg

Patient Medication Information: uses, side effects, how to take - Pramipexole (Cobalt Pharmaceuticals)

ABOUT THIS MEDICATION

What the medication is used for:

PRAMIPEXOLE is used to treat early and late stage Parkinson’s disease. PRAMIPEXOLE provides relief of signs and symptoms of Parkinson’s disease. Signs and symptoms of the disease include: shaking (tremor), slowness in performing activities of daily living (bradykinesia), muscle stiffness (rigidity) and mood changes (depression). In late stage Parkinson’s disease, PRAMIPEXOLE will be used in combination with levodopa.

What it does:

PRAMIPEXOLE belongs to a group of medicines known as “dopamine agonists”. PRAMIPEXOLE improves some of the chemical imbalance in the part of the brain affected by Parkinson’s disease.

When it should not be used:

If you are allergic to pramipexole, or any of the nonmedicinal ingredients of the product (see list below). PRAMIPEXOLE is not recommended for children under 18 years of age.

What the medicinal ingredient is:

Pramipexole dihydrochloride monohydrate.

What the important nonmedicinal ingredients are:

Collodal silicon dioxide, magnesium stearate, mannitol, povidone, starch (corn).

What dosage forms it comes in:

0.25 mg, 0.5 mg, 1.0 mg, and 1.5 mg tablets.

WARNINGS AND PRECAUTIONS

You are warned of a sudden onset of sleep condition which may occur without warning, while taking PRAMIPEXOLE. You should not operate machinery or engage in activities that require alertness, as you may put yourself and others at risk of serious injury or death. This sudden onset of sleep condition has also been reported in patients taking other anti-Parkinson drugs of the same class.

Studies of people with Parkinson’s disease show that they may be at an increased risk of developing melanoma (a form of skin cancer) when compared to people without Parkinson’s disease. It

is not known if this problem is associated with Parkinson’s disease or the drugs used to treat Parkinson’s disease. PRAMIPEXOLE is one of the drugs used to treat Parkinson’s disease; therefore, patients treated with PRAMIPEXOLE should have periodic skin examinations.

Patients and caregivers should be aware of the fact that abnormal behaviour such as pathological gambling, increased sexual desire, excessive sexual activity, compulsive shopping or binge eating have been reported. Those changes have also been reported in patients taking other anti-Parkinson drugs of the same class.

BEFORE you use PRAMIPEXOLE talk to your doctor or pharmacist:

$ if you have any health problems, especially kidney problems or blood pressure problems;

$ if you have any unusual conditions related to your eyes or eyesight;

$ if you have previously taken pramipexole

dihydrochloride tablets and became unwell; $ if you have any allergies or reactions to foods or drugs; $ if you are pregnant or intend to become pregnant; $ if you are breast feeding;

$ if you are taking any other medications, including any drugs you can buy without a prescription. $ if you drive a vehicle or perform hazardous tasks during your work.

INTERACTIONS WITH THIS MEDICATION

Other medications may be affected by PRAMIPEXOLE or may affect how PRAMIPEXOLE works. Do not take any other medication, including over-the-counter medications or herbal products unless your doctor tells you to. Tell any other doctor, dentist or pharmacist that you talk to that you are taking PRAMIPEXOLE.

Avoid alcohol or other sedatives while taking PRAMIPEXOLE.

PROPER USE OF THIS MEDICATION

Usual Adult dose:

Parkinson’s disease

Take PRAMIPEXOLE in equal doses, three times daily as prescribed by your doctor. Dosages should be increased gradually from a starting dose of 0.125 mg three times daily and should not be increased more frequently than every 5 to 7 days. It is important that your doctor increases your dosage of PRAMIPEXOLE gradually to avoid side effects and to achieve the best therapeutic effect. Your dose will probably change each week until your doctor and you decide what the best dose is for you. Make sure that you only use the tablet strength that your doctor has prescribed. The maximal recommended dose of PRAMIPEXOLE is 4.5 mg per day. Lower doses are recommended for patients with kidney disease.

Your doctor may decide to lower your dose of levodopa to prevent excessive side effects and to make sure that you are getting the best results from both drugs. Pay close attention to

your doctor’s instructions and never change the dose of either drug yourself.

You should not change the dose or discontinue treatment with PRAMIPEXOLE without the recommendation of your doctor.

You may take PRAMIPEXOLE without food or with food if you find that you feel sick to your stomach while taking the tablets.

Overdose:

If you accidentally take too many tablets, you should get medical help immediately; either by calling your doctor or by going to the nearest hospital (do not drive yourself). Always take the labelled medicine container with you whether or not there are any PRAMIPEXOLE tablets left.

In the event of overdosage, contact your doctor, hospital emergency department or regional Poison Control Centre immediately.

Missed Dose:

If you forget to take a dose, take it as soon as you remember, then carry on as before. However, if it is almost time for your next dose, skip the dose you missed and take the next dose when you are supposed to. Do not take more than one dose at a time.

PRAMIPEXOLE has been prescribed for you. Do not give these tablets to anyone else, even if you think they have the same condition as you.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

You should be aware that prescription medicines carry some risks and that all possible risks may not be known at this stage. Discuss with your doctor the risks of taking PRAMIPEXOLE against the expected benefits.

  • PRAMIPEXOLE may cause unwanted effects such as nausea,

    constipation, sleepiness, dream abnormalities, amnesia, fatigue, muscle weakness, accidental injury and confusion. If you do experience any unusual or unwanted effects while you are taking PRAMIPEXOLE, be sure to tell your doctor. It is important that he/she knows of any unwanted effects to determine the best dose of PRAMIPEXOLE for you.

  • PRAMIPEXOLE does not usually affect people’s normal

    activities. However, some people may feel dizzy or sleepy while taking PRAMIPEXOLE, especially during the first few weeks of treatment.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor or pharamcistStop taking drug and call your doctor or pharmacist
Only if severeIn all cases
CommonDyskinesia (Difficulty performing voluntary movements)T
Hallucinations (see, hear, smell, taste or feel some-thing that is not there)T

Insomnia

(Difficulty falling asleep)

T

Low blood

pressure with

dizziness when rising to a sitting or standing

position. You may feel sick, light-headed, faint or you may sweat.

T
Uncommon

Behavioural

changes such as compulsive

gambling,

compulsive

shopping, changes in sexual desire or sexual activity, increased eating

T
Delusion (a false belief, despite incontrovertible evidence, that something is false)T

Paranoia

(unrealistic and excessive anxiety and worry)

T
Sudden onset of sleepT

Do not be alarmed by this list of possible side effects. You may not experience any of them. This is not a complete list of side effects. For any unexpected effects while taking PRAMIPEXOLE, contact your doctor or pharmacist immediately, so that these effects may be properly addressed.

HOW TO STORE IT

  • Keep this drug away from light and moisture.
  • PRAMIPEXOLE should be stored between 15 and 25EC.
  • The expiry date of this medicine is printed on the label. Do not use the medicine after this date.
  • Keep this drug out of the reach of children.

    REPORTING SUSPECTED SIDE EFFECTS You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

    ---------------------------------------------------------------------------- $ Report online at www.healthcanada.gc.ca/medeffect $ Call toll-free at 1-866-234-2345

    $ Complete a Canada Vigilance Reporting Form and:

    • Fax toll-free to 1-866-678-6789, or
    • Mail to: Canada Vigilance Program Health Canada

      Postal Locator 0701C

      Ottawa, ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be obtained by contacting the sponsor, Cobalt Pharmaceuticals Inc., at: 1-866-254-6111.

Cobalt Pharmaceuticals Inc.

Mississauga, ON

Canada, L5N 2B8

Last revised: February 9, 2010

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02344270

Revision date stated in the text: February 9, 2010

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Pramipexole (Cobalt Pharmaceuticals)

Rx or OTC
Prescription (Rx)?
DIN 02344270, 02344289, 02344297, 02344300
Schedule(s) PRESCRIPTION
Active ingredient(s) Pramipexole dihydrochloride monohydrate
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N04 Anti-parkinson drugs
      1. N04B Dopaminergic agents
        1. N04BC Dopamine agonists
          1. N04BC05 Pramipexole
Company COBALT PHARMACEUTICALS COMPANY
Current status Cancelled Pre Market
Current status date September 1, 2017
Strengths and forms
DIN Strength Dosage form(s) Current status
02344270 0.25 MG Tablet Cancelled Pre Market September 1, 2017
02344289 0.5 MG Tablet Cancelled Pre Market September 1, 2017
02344297 1.0 MG Tablet Cancelled Pre Market September 1, 2017
02344300 1.5 MG Tablet Cancelled Pre Market September 1, 2017

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.